arrow
T

Tomoyasu Jo

kyoto university
H指数:14
被引数:585

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Absence of Pretransplant Peripheral Blasts is Favorable Factor in Allogeneic Stem Cell Transplantation for Advanced Acute Lymphoblastic Leukemia

移植前外周血 blasts 缺失是异基因干细胞移植治疗进展期急性淋巴细胞白血病的有利因素

2026-06-230
PRE
Prolonged Cytokine Release Syndrome Is Associated With Hypofibrinogenemia After CD19-Directed CAR T-Cell Therapy in Adult Patients With Relapsed/Refractory Lymphoma

成人复发/难治性淋巴瘤患者接受CD19靶向CAR T细胞治疗后,长期细胞因子释放综合征与低纤维蛋白原血症相关

2026-05-210
OAAI
Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients

CD34+细胞剂量对成人AML患者相关异基因PBSCT预后的影响

2026-04-280
OAAI
Drivers of Temporal Improvement in CAR T-Cell Therapy for Large B-Cell Lymphoma: A Japanese Nationwide Registry Analysis

大B细胞淋巴瘤CAR T细胞疗法的时效性改善驱动因素:一项日本全国注册登记分析

2026-04-250
OAAI
Decreased renal function predicts severe cytokine release syndrome after CAR-T-cell therapy for large B-cell lymphoma

肾功能下降预示大B细胞淋巴瘤CAR-T细胞治疗后严重细胞因子释放综合征

2026-04-150
PRE
Neutrophils predominate as IL1B-expressing cells in Schnitzler syndrome: Insights from the SCan study to evaluate the efficacy and safety of canakinumab in Japanese patients

中性粒细胞作为IL1B表达细胞在施尼茨综合征中占主导地位:来自SCan研究对日本患者中卡那奴单抗疗效和安全性的评估见解

2025-10-012
OAAI
Impact of methotrexate-dosing regimens for GVHD prophylaxis on clinical outcomes of HLA-matched allogeneic HSCT

甲氨蝶呤给药方案对HLA匹配异基因造血干细胞移植中GVHD预防的临床结局的影响

2025-10-010
OAAI
Machine learning evaluation of intensified conditioning on haematopoietic stem cell transplantation in adult acute lymphoblastic leukemia patients
2024-11-250
OAAI
Clinical Impact of Cytokine Release Syndrome on Prolonged Hematotoxicity after Chimeric Antigen Receptor T Cell Therapy: KyoTox A-Score, a Novel Prediction Model

细胞因子释放综合征对嵌合抗原受体T细胞治疗后长期血液毒性的临床影响: KyoTox A评分,一种新的预测模型

2024-04-018
OAAI